1. Home
  2. QNCX vs CHCI Comparison

QNCX vs CHCI Comparison

Compare QNCX & CHCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$4.24

Market Cap

139.2M

Sector

Health Care

ML Signal

HOLD

CHCI

Comstock Holding Companies Inc.

HOLD

Current Price

$13.75

Market Cap

139.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNCX
CHCI
Founded
2012
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
139.2M
139.7M
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
QNCX
CHCI
Price
$4.24
$13.75
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.75
N/A
AVG Volume (30 Days)
1.1M
25.5K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.40
EPS
N/A
1.33
Revenue
N/A
$55,836,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$9.67
Revenue Growth
N/A
22.98
52 Week Low
$0.72
$6.31
52 Week High
$4.55
$18.99

Technical Indicators

Market Signals
Indicator
QNCX
CHCI
Relative Strength Index (RSI) 75.56 38.64
Support Level $3.74 $13.51
Resistance Level $4.30 $14.20
Average True Range (ATR) 0.46 0.53
MACD 0.10 -0.03
Stochastic Oscillator 86.67 0.00

Price Performance

Historical Comparison
QNCX
CHCI

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About CHCI Comstock Holding Companies Inc.

Comstock Holding Co Inc is a developer and manager of mixed-use and transit-oriented properties with operations that are majorly focused on the Washington, D.C. metropolitan area. It provides a range of services such as asset management, property management, development and construction management, and other real estate-related services to its asset-owning clients, composed predominantly of institutional real estate investors, high net worth family offices, financial institutions, and governmental bodies seeking to enhance their surrounding communities by developing real estate through public-private partnerships.

Share on Social Networks: